-
DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript
01 Apr 2024 18:39 GMT
… Transcript March 27, 2024
DURECT Corporation beats earnings expectations. … afternoon and welcome to DURECT Corporation’s fourth quarter 2023 … A Session Follow Durect Corp (NASDAQ:DRRX) Follow Durect Corp (NASDAQ:DRRX) … as die from breast cancer. And it’s a …
-
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
28 Mar 2024 11:25 GMT
… 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial … , including acute organ injury and cancer. Larsucosterol, DURECT's … health authorities for any indication.
DURECT CORPORATION
CONDENSED STATEMENTS OF OPERATIONS AND …
-
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update
21 Mar 2024 08:47 GMT
… acute organ injury and cancer, today announced that the … acute organ injury and cancer. Larsucosterol, DURECT… is a trademark of DURECT Corporation. Other referenced trademarks belong … update-302095096.html
SOURCE DURECT Corporation
Company Codes: NASDAQ- …
-
DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
08 Feb 2024 10:46 GMT
… , 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that … , including acute organ injury and cancer. Larsucosterol, DURECT's lead … -sciences-conference-302056826.html
SOURCE DURECT Corporation
Company Codes: NASDAQ-NMS:DRRX
-
DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business Update
09 Nov 2023 22:19 GMT
… #47;PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a late … acute organ injury and cancer, today announced that the … acute organ injury and cancer. Larsucosterol, DURECT… is a trademark of DURECT Corporation. Other referenced trademarks belong …
-
DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on Mortality
08 Nov 2023 15:28 GMT
… , including acute organ injury and cancer, today announced topline results from … , including acute organ injury and cancer. Larsucosterol, DURECT's lead … -on-mortality-301980628.html
SOURCE DURECT Corporation
Company Codes: NASDAQ-NMS:DRRX
-
DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis
07 Sep 2023 15:19 GMT
… , including acute organ injury and cancer, today announced that the last … and certain chronic diseases.
About DURECT Corporation
DURECT is a biopharmaceutical company … . SABER® is a trademark of DURECT Corporation. Other referenced trademarks belong to …
-
DURECT Corporation (NASDAQ:DRRX) Q2 2023 Earnings Call Transcript
11 Aug 2023 17:55 GMT
… are important targets for various cancers in the hematology space. Currently … resource allocation between these upcoming cancer programs and potential expansion into … for your participation. Follow Durect Corp (NASDAQ:DRRX) Follow Durect Corp (NASDAQ:DRRX) We …
-
DURECT Corporation Announces Appointment of Gail Maderis as Chair of the Board
22 Mar 2023 12:16 GMT
… , 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that … therapies to treat the pre-cancerous lesions caused by HPV, since … alcohol-associated hepatitis."
About DURECT Corporation
DURECT is a biopharmaceutical company …
-
DURECT Corporation's (DRRX) CEO Jim Brown on Q4 2021 Results - Earnings Call Transcript
08 Mar 2022 07:01 GMT
DURECT Corporation (NASDAQ:DRRX) Q4 2021 … And welcome to the DURECT Corporation Fourth Quarter 2021 Earnings Call … Arenberg, Chief Financial Officer of DURECT Corporation.
Before beginning, I would … of epigenetics, not an anti-cancer kind of circumstance, but …